Lomitapide mesylate

Lomitapide mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of lomitapide and methanesulfonic acid. Used as a complement to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. Among its listed roles, it functions as a anticholesteremic drug and a MTP inhibitor. It includes a lomitapide(1+). It is grouped under the following drug class(es): Cholesterol-reducing agents and Lipid-lowering agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lomitapide Methanesulfonate, Juxtapid (TN) and Lojuxta (TN). Its PubChem CID is 11274333.

CAS No 202914-84-9
Molecular Formula C40H41F6N3O5S
Molecular Weight 789.80 g/mol
Synonyms methanesulfonic acid;N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide

Frequently Asked Questions